Elsa Curtit

Besancon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Evaluating the investigational drug landscape for ESR1-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Evaluating the investigational drug landscape for ESR1-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Journal: Expert opinion on investigational drugs
Published: June 08, 2026

Germline BRCA1/2 Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in France.

Germline BRCA1/2 Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in France.

Journal: Cancers
Published: January 22, 2026

Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy.

Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy.

Journal: Breast cancer research and treatment
Published: October 28, 2025

Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy.

Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy.

Journal: Cancers
Published: September 12, 2025

Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study).

Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study).

Journal: Journal of cancer research and clinical oncology
Published: April 25, 2025

Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors.

Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors.

Journal: Breast cancer research : BCR
Published: March 10, 2025

Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 20, 2024

Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption.

Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption.

Journal: Breast cancer research : BCR
Published: August 26, 2024

Postcancer rehabilitation: multidisciplinary exercise - programme organisation and feasibility.

Postcancer rehabilitation: multidisciplinary exercise - programme organisation and feasibility.

Journal: BMJ supportive & palliative care
Published: July 01, 2024

Exercise Intervention on Insomnia in Patients with a Cancer: A Systematic Review of the Literature.

Exercise Intervention on Insomnia in Patients with a Cancer: A Systematic Review of the Literature.

Journal: Cancers
Published: April 30, 2024

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.

Journal: Clinical breast cancer
Published: March 09, 2024

The French National College of Oncology Teachers (CNEC): Missions, organization, and projects

The French National College of Oncology Teachers (CNEC): Missions, organization, and projects

Journal: Bulletin du cancer
Published: December 21, 2023
Showing 1-12 of 51

Last Updated: 09/26/2026